Dermatol. praxi. 2013;7(4):152-155

Conventional treatment of chronic plaque psoriasis in the era of biological drugs

MUDr.Alena Machovcová, Ph.D., MBA
Dermatovenerologické oddělení FN v Motole, Praha

Despite undeniable progress in the treatment, psoriasis still remains an incurable condition. Systemic treatment is indicated in patients

with moderate and severe forms of plaque psoriasis or with other forms of psoriasis. Conventional systemic treatment utilizes retinoids,

ciclosporin or methotrexate with a varied effect and, more recently, modern biological therapy has been used which is very effective.

The article deals with systemic psoriasis treatment prior to initiation of biological therapy, evaluation of treatment efficacy, and side

effects of treatment.

Keywords: plaque psoriasis, psoriasis severity, conventional systemic psoriasis treatment

Published: December 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Machovcová A. Conventional treatment of chronic plaque psoriasis in the era of biological drugs. Dermatol. praxi. 2013;7(4):152-155.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Aydin F, Canturk T, Senturk N, Turanli AY. Methotrexate and ciclosporin combination for the treatment of severe psoriasis. Clin Exp Derm 2006; 31: 520-524. Go to original source... Go to PubMed...
    2. Bologna JL, Jorizzo JL, Rapini RP, et al. Dermatology. Volume I, Mosby London 2003. ISBN 0323024092.
    3. Cetkovská P, Kojanová M. Česká doporučení k biologické léčbě závažné chronické ložiskové psoriázy. Čes-slov Derm 2012; 87(1): 1-76.
    4. Cohen SN, Baron SE, Archer CB. Guidance on the diagnosis and clinical management of psoriasis. Clin Exp Derm 2012; 37: 13-18. Go to original source... Go to PubMed...
    5. Kipnis CD, Myers WA, Opeola M, et al. Biologic treatment for psoriasis. J Am Acad Dermatol 2005; 52: 671-682. Go to original source... Go to PubMed...
    6. Lebwohl M. Innovations in the treatment of psoriasis. J Am Acad Dermatol 2004; 51(1): 40-S41. Go to original source... Go to PubMed...
    7. Malina L. Co je nového v terapii psoriázy. Čes.-slov. Derm. 2003; 78(6): 247-250.
    8. Martínek V, Matoušovic K, Špatenka J. Objev a užití cyklosporinu v klinické praxi. Prak. Lék. 2002; 82(1): 14-20.
    9. Švecová D. Pokroky v novodobé léčbě psoriázy. Čes.-slov. Derm. 2002; 77(1): 12-18.
    10. Malina L. Co je nového v terapii psoriázy. Čes.-slov. Derm. 2003; 78(6): 247-250.
    11. Koo J, Lee E, Lee ChS, et al. J Am Acad Dermatol 2004; 50: 613-622. Go to original source... Go to PubMed...
    12. Mrowietz U, Kragballe K, Reich K, et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 2011; 303(1): 1-10. Go to original source... Go to PubMed...
    13. Nast A, Boehncke WH, Mrowietz U, et al. S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update. JDDG 2012; 10: S1-S95. Go to original source... Go to PubMed...
    14. Paul C, Gourraud PA, Bronsard V, et al. Evidence-based recommendations to assess psoriasis severity: systematic literature review and expert opinion of a panel of dermatologists. JEADV 2010; 24: 2-9. Go to original source... Go to PubMed...
    15. Warren RB, Chalmers RJG, Griffiths CEM, Menter A. Methotrexate for psoriasis in the era of biological therapy. Clin Exp Derm 2008; 33: 551-554. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.